Baader Bank Aktiengesellschaft’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-113
Closed -$3.84K – 435
2024
Q3
$3.84K Buy
+113
New +$5.76K ﹤0.01% 423

Other funds holding MTRI

Baader Bank Aktiengesellschaft's MTRI Position: Q4 2024 in Review

Baader Bank Aktiengesellschaft sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q4 2024, closing a stake of 113 shares — an estimated $3.84K sold.

Baader Bank Aktiengesellschaft first reported a position in MTRI in Q3 2024 and held it in 1 quarter. The position peaked at $3.84K in Q3 2024. 2 funds tracked by Wall St. Rank hold MTRI as of Q4 2024.

  • Baader Bank Aktiengesellschaft reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 113 Mentari Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $3.84K.
  • Baader Bank Aktiengesellschaft first reported a position in Mentari Therapeutics, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Mentari Therapeutics, Inc. Common Stock position peaked at $3.84K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2024, filed 23 Jan 2025.